ADC Therapeutics SA — Investor Relations & Filings
Filings indexed
396
across all filing types
Latest filing
2026-05-04
Regulatory Filings
Country
US
United States of America
Listing
US
ADCT
ADC Therapeutics SA is a commercial-stage biotechnology company pioneering the development of antibody-drug conjugates (ADCs) for cancer therapy. The company focuses on creating highly potent and targeted ADCs to treat hematologic malignancies and solid tumors, addressing significant unmet medical needs. Its primary product, ZYNLONTA® (loncastuximab tesirine-lpyl), is an FDA-approved anti-CD19 ADC for adults with relapsed or refractory large B-cell lymphoma. The company's research and development pipeline includes a next-generation PSMA-targeting ADC that utilizes a differentiated exatecan-based payload with a novel hydrophilic linker, aimed at treating solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - ADC Therapeutics SA (0001771910) (Filer) | 2026-05-04 | English | |
| DEF 14A - ADC Therapeutics SA (0001771910) (Filer) | 2026-04-20 | English | |
| EFFECT - ADC Therapeutics SA (0001771910) (Filer) | 2026-03-17 | English | |
| 8-K - ADC THERAPEUTICS SA (0001771910) (Filer) | 2026-02-23 | English | |
| 4 - ADC THERAPEUTICS SA (0001771910) (Filer) | 2026-02-18 | English | |
| 4 - ADC THERAPEUTICS SA (0001771910) (Filer) | 2026-02-18 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 40883041 | 8-K - ADC Therapeutics SA (0001771910) (Filer) | 2026-05-04 | English | ||
| 34691265 | DEF 14A - ADC Therapeutics SA (0001771910) (Filer) | 2026-04-20 | English | ||
| 32962993 | EFFECT - ADC Therapeutics SA (0001771910) (Filer) | 2026-03-17 | English | ||
| 32898023 | 8-K - ADC THERAPEUTICS SA (0001771910) (Filer) | 2026-02-23 | English | ||
| 32898018 | 4 - ADC THERAPEUTICS SA (0001771910) (Filer) | 2026-02-18 | English | ||
| 32898019 | 4 - ADC THERAPEUTICS SA (0001771910) (Filer) | 2026-02-18 | English | ||
| 32898021 | 4 - ADC THERAPEUTICS SA (0001771910) (Filer) | 2026-02-18 | English | ||
| 32898020 | 4 - ADC THERAPEUTICS SA (0001771910) (Filer) | 2026-02-18 | English | ||
| 32898022 | 4 - ADC THERAPEUTICS SA (0001771910) (Filer) | 2026-02-18 | English | ||
| 31657188 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31657048 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31657045 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31657109 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 13170966 | FORM 8-K | 2026-01-12 | English | ||
| 13170967 | 8-K | 2026-01-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
|
AFC-HD AMS Life Science Co.,Ltd.
An OEM of health foods, supplements, and cosmetics with int…
|
2927 | JP | Manufacturing |
ADC Therapeutics SA via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32916/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32916 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32916 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32916 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32916}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ADC Therapeutics SA (id: 32916)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.